Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Centocor ( CNTO ) -- Ignore unavailable to you. Want to Upgrade?

To: FNS who wrote (506)	1/13/1998 2:00:00 PM
From: FNS	Read Replies (1) \| Respond to of 965

I was told that there is a First Call out on CNTO. Then received the following information from a broker: "CNTO is down today on misleading news. The American Heart Assoc. published an article suggesting ReoPro be used for up to six months following a heart attack. Several analysts said the article gave the false impression that ReoPro isn't working in shorter durations which is obviously not the case." I have not seen the First Call not the article... The stock has recovered somewhat, but still down considerably, around 30 1/8. FNS